Arno Therapeutics, Inc. (OTCMKTS:ARNI – Get Free Report)’s share price passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.00 and traded as high as $0.00. Arno Therapeutics shares last traded at $0.00, with a volume of 0 shares trading hands.
Arno Therapeutics Trading Down 100.0 %
Arno Therapeutics Company Profile
Arno Therapeutics, Inc, a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company’s product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men.
Read More
- Five stocks we like better than Arno Therapeutics
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Dividend Capture Strategy: What You Need to Know
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Technology Stocks Explained: Here’s What to Know About Tech
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Arno Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arno Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
